Wedbush Raises Price Target on Raptor Pharmaceuticals (RPTP), Successful Phase III trial for RP103
Go back to Wedbush Raises Price Target on Raptor Pharmaceuticals (RPTP), Successful Phase III trial for RP103| RAPTOR PHARM (NASDAQ: RPTP) | Delayed: 9.00 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.00 | 52 Week High | $9.05 | |||
| Open | $18.25 | 52 Week Low | $2.94 | |||
| Day High | $9.00 | P/E | N/A | |||
| Day Low | $9.00 | EPS | $-0.37 | |||
| Volume | 588,079 | |||||
